Procedure: CT-guided left L5 nerve root block.
Medications: 1% lidocaine local anesthesia, 1.0 ml 0.25% bupivacaine ,
1.0 ml Kenalog (40 mg/ml)
Complications: None.
FINDINGS:
Description:
After the procedure, including indications and potential complications,
had been discussed with the patient and questions answered, written
informed consent was obtained. A time out was performed. The patient was
then taken to the CT suite and placed on the CT table in prone position
with the skin of the back was prepped and draped in the standard sterile
fashion. Local anesthesia was achieved with 1% lidocaine. Under
intermittent CT guidance a 22-gauge spinal needle was advanced to the
soft tissues of the back until the tip of the needle resided adjacent to
the left L5 nerve root. 1.0 ml 0.25% bupivacaine and 1.0 ml Kenalog (40
mg/ml) were injected adjacent to the nerve root and the needle withdrawn.
The patient tolerated the procedure well without immediate complication
and was discharged in stable condition after a period of observation.
Pre-procedure pain of 10/10 was noted to be 5/10 immediately following
the procedure. The patient was given instructions for followup and was
told that multiple treatments may be necessary to alleviate her back/leg
pain.
IMPRESSION:
Technically successful left L5 nerve root injection as above.
Medications: 1% lidocaine local anesthesia, 1.0 ml 0.25% bupivacaine ,
1.0 ml Kenalog (40 mg/ml)
Complications: None.
FINDINGS:
Description:
After the procedure, including indications and potential complications,
had been discussed with the patient and questions answered, written
informed consent was obtained. A time out was performed. The patient was
then taken to the CT suite and placed on the CT table in prone position
with the skin of the back was prepped and draped in the standard sterile
fashion. Local anesthesia was achieved with 1% lidocaine. Under
intermittent CT guidance a 22-gauge spinal needle was advanced to the
soft tissues of the back until the tip of the needle resided adjacent to
the left L5 nerve root. 1.0 ml 0.25% bupivacaine and 1.0 ml Kenalog (40
mg/ml) were injected adjacent to the nerve root and the needle withdrawn.
The patient tolerated the procedure well without immediate complication
and was discharged in stable condition after a period of observation.
Pre-procedure pain of 10/10 was noted to be 5/10 immediately following
the procedure. The patient was given instructions for followup and was
told that multiple treatments may be necessary to alleviate her back/leg
pain.
IMPRESSION:
Technically successful left L5 nerve root injection as above.